Milind Javle, Attending Physician at MD Anderson Cancer Center, shared on LinkedIn:
“Congratulations to all the investigators on Oncosil HDE approval by the FDA! Another huge milestone for Cholangiocarcinoma. Thanks to the investigators at UT MD Anderson Cholangiocarcinoma Foundation and OncoSil Medical”
You can also read: ‘FDA Approves OncoSil Device for Distal Cholangiocarcinoma‘
